2.25
2.60%
-0.06
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
14000 Shares in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Bought by NBC Securities Inc. - Defense World
Defense World
How Do Things Look For Acurx Pharmaceuticals Inc (NASDAQ: ACXP) In The Short-Term? – Stocks Register - Stocks Register
Stocks Register
Closing Strong: Acurx Pharmaceuticals Inc (ACXP) Ends at 2.25, Down -5.46 from Last Close – DWinneX - The Dwinnex
The Dwinnex
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest - Defense World
Defense World
Acurx Pharmaceuticals (NASDAQ:ACXP) Trading Up 6.3% - Defense World
Defense World
Acurx Pharmaceuticals (NASDAQ:ACXP) Trading Up 6.3% - Defense World
Defense World
New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored ... - GlobeNewswire
GlobeNewswire
New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored ... - Yahoo Canada Finance
Yahoo Canada Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Acurx Pharmaceuticals (NASDAQ:ACXP), Biodexa ... - Benzinga
Benzinga
Q2 2024 Earnings Forecast for Cabaletta Bio, Inc. Issued By HC Wainwright (NASDAQ:CABA) - Defense World
Defense World
HC Wainwright Reiterates Buy Rating for Acurx Pharmaceuticals (NASDAQ:ACXP) - Defense World
Defense World
Acurx reports results from meeting with FDA regarding ibezapolstat - TipRanks
TipRanks
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Rises By 6.3% - Defense World
Defense World
Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Rises By 6.3% - Defense World
Defense World
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress - Investing.com India
Investing.com India
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress - Investing.com India
Investing.com India
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com - Investing.com
Investing.com
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com - Investing.com UK
Investing.com UK
Acurx gears up for Phase 3 trials of CDI antibiotic candidate - Investing.com Australia
Investing.com Australia
Acurx gears up for Phase 3 trials of CDI antibiotic candidate - Investing.com South Africa
Investing.com South Africa
Acurx Pharmaceuticals Reports First Quarter 2024 Results and Provides Business Update - citybiz
citybiz
Acurx Pharmaceuticals, Inc. (ACXP) Q1 2024 Earnings Call Transcript - Seeking Alpha
Seeking Alpha
Acurx gears up for Phase 3 trials of CDI antibiotic candidate - Investing.com
Investing.com
Earnings call: Acurx Pharmaceuticals outlines ibezapolstat progress By Investing.com - Investing.com
Investing.com
Infectious disease index continues decline despite positive news - BioWorld Online
BioWorld Online
Infectious disease index continues decline despite positive news - BioWorld Online
BioWorld Online
Acurx Pharmaceuticals (ACXP) Scheduled to Post Quarterly Earnings on Wednesday - Defense World
Defense World
Lion Electric reports US$21.7M Q1 loss compared with US$15.6M loss a year earlier - Yahoo News Canada
Yahoo News Canada
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - Yahoo Canada Finance
Yahoo Canada Finance
CaliberCos (CWD) versus Its Rivals Critical Comparison - Defense World
Defense World
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Benzinga
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
Acurx Pharmaceuticals, Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Nasdaq
La Rosa Holdings Corp. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Nasdaq
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks - Insider Monkey
Insider Monkey
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Acurx Pharmaceuticals Inc Down 1.84% To $2.67 After Earnings Miss - InvestorsObserver
InvestorsObserver
Acurx Pharmaceuticals Shares Fall 26% On Stock-Offering News - MarketWatch
MarketWatch
Feyi-Waboso out of England Six Nations camp to take uni exam - Yahoo Finance UK
Yahoo Finance UK
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series - GlobeNewswire
GlobeNewswire
New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network ... - Yahoo Finance
Yahoo Finance
New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday ... - GlobeNewswire
GlobeNewswire
Acurx Stock: Sell-off Presents Opportunity Before Upcoming Data Release - Seeking Alpha
Seeking Alpha
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today? - Yahoo Finance
Yahoo Finance
Why Acurx Pharmaceuticals (ACXP) Shares Are Falling Today - Acurx Pharmaceuticals (NASDAQ:ACXP) - Benzinga
Benzinga
New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored ... - Yahoo Finance
Yahoo Finance
Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment (NASDAQ:ACXP) - Seeking Alpha
Seeking Alpha
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):